Search research articles
Contact Us
Filters
Showing results (51-60 of 84) with videos related to
Page
of 9
Sort By:
Drug Discovery Today
|
November 28, 2015
Assessment of cognitive safety in clinical drug development
Jonathan P Roiser, Pradeep J Nathan, Adrian P Mander, et al.
Clinical Trials (London, England)
|
December 21, 2019
Designing and evaluating dose-escalation studies made easy: The MoDEsT web app
Philip Pallmann, Fang Wan, Adrian P Mander, et al.
The British Journal of Nutrition
|
September 26, 2013
Age and sex differences in the incorporation of EPA and DHA into plasma fractions, cells and adipose tissue in humans
Celia G Walker, Lucy M Browning, Adrian P Mander, et al.
Journal of Clinical Epidemiology
|
July 5, 2022
Subgroup analyses in randomized controlled trials frequently categorized continuous subgroup information
S Faye Williamson, Michael J Grayling, Adrian P Mander, et al.
BMC Public Health
|
January 25, 2011
Dietary energy density and adiposity: employing bias adjustments in a meta-analysis of prospective studies
Désirée C Wilks, Adrian P Mander, Susan A Jebb, et al.
The Journal of Nutrition
|
October 29, 2010
How much human milk do infants consume? Data from 12 countries using a standardized stable isotope methodology
Teresa H M da Costa, Hinke Haisma, Jonathan C K Wells, et al.
The Journal of Nutrition
|
March 21, 2014
Compared with daily, weekly n-3 PUFA intake affects the incorporation of eicosapentaenoic acid and docosahexaenoic acid into platelets and mononuclear cells in humans
Lucy M Browning, Celia G Walker, Adrian P Mander, et al.
Plos One
|
March 9, 2011
Objectively measured physical activity and fat mass in children: a bias-adjusted meta-analysis of prospective studies
Desiree C Wilks, Stephen J Sharp, Ulf Ekelund, et al.
Diabetes Care
|
September 23, 2022
Innovative Designs and Logistical Considerations for Expedited Clinical Development of Combination Disease-Modifying Treatments for Type 1 Diabetes
Randy L Anderson, Linda A DiMeglio, Adrian P Mander, et al.
British Journal of Cancer
|
August 12, 2015
A Bayesian adaptive design for biomarker trials with linked treatments
James M S Wason, Jean E Abraham, Richard D Baird, et al.
Page
of 9
Search research articles
Search
Showing results (51-60 of 84) with videos related to
Sort By:
Page
of 9
Drug Discovery Today
|
November 28, 2015
Assessment of cognitive safety in clinical drug development
Jonathan P Roiser, Pradeep J Nathan, Adrian P Mander, et al.
Clinical Trials (London, England)
|
December 21, 2019
Designing and evaluating dose-escalation studies made easy: The MoDEsT web app
Philip Pallmann, Fang Wan, Adrian P Mander, et al.
The British Journal of Nutrition
|
September 26, 2013
Age and sex differences in the incorporation of EPA and DHA into plasma fractions, cells and adipose tissue in humans
Celia G Walker, Lucy M Browning, Adrian P Mander, et al.
Journal of Clinical Epidemiology
|
July 5, 2022
Subgroup analyses in randomized controlled trials frequently categorized continuous subgroup information
S Faye Williamson, Michael J Grayling, Adrian P Mander, et al.
BMC Public Health
|
January 25, 2011
Dietary energy density and adiposity: employing bias adjustments in a meta-analysis of prospective studies
Désirée C Wilks, Adrian P Mander, Susan A Jebb, et al.
The Journal of Nutrition
|
October 29, 2010
How much human milk do infants consume? Data from 12 countries using a standardized stable isotope methodology
Teresa H M da Costa, Hinke Haisma, Jonathan C K Wells, et al.
The Journal of Nutrition
|
March 21, 2014
Compared with daily, weekly n-3 PUFA intake affects the incorporation of eicosapentaenoic acid and docosahexaenoic acid into platelets and mononuclear cells in humans
Lucy M Browning, Celia G Walker, Adrian P Mander, et al.
Plos One
|
March 9, 2011
Objectively measured physical activity and fat mass in children: a bias-adjusted meta-analysis of prospective studies
Desiree C Wilks, Stephen J Sharp, Ulf Ekelund, et al.
Diabetes Care
|
September 23, 2022
Innovative Designs and Logistical Considerations for Expedited Clinical Development of Combination Disease-Modifying Treatments for Type 1 Diabetes
Randy L Anderson, Linda A DiMeglio, Adrian P Mander, et al.
British Journal of Cancer
|
August 12, 2015
A Bayesian adaptive design for biomarker trials with linked treatments
James M S Wason, Jean E Abraham, Richard D Baird, et al.
Page
of 9